GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
Items 301–400 of 561
Herzog, A. G., Mandle, H. B., Cahill, K. E., Fowler, K. M., & Hauser, W. A. (2016) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2016.04.020 · Cited by 38
Plasticity of GABAA Receptors during Pregnancy and Postpartum Period: From Gene to Function
Licheri, V., Talani, G., Gorule, A. A., Mostallino, M. C., Biggio, G., & Sanna, E. (2015) · Neural Plasticity · doi:10.1155/2015/170435 · Cited by 36
“Moreover, the expression of δ subunit is accompanied by similar and parallel changes in α4 subunit [56, 63–65, 72–74] that make GABAARs responsible for tonic inhibition.”
BackgroundNeuroactive Properties of Reproductive Steroids
Herzog, A. G. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00817.x · Cited by 34
Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin
Tait, G. R., McManus, K., Bellavance, F., Lara, N., Chrapko, W. E., & Mellédo, J. L. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00051-8 · Cited by 36
Oral contraceptives and neuroactive steroids
Rapkin, A. J., Biggio, G., & Concas, A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.06.008 · Cited by 38
Banerjee, P., Tillakaratne, N. J. K., Brailowsky, S., Olsen, R. W., Tobin, A. J., & Snead, O. C. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6928 · Cited by 39
Nin, M. S., Salles, F., de Azeredo, L. A., Frazon, A., Gomez, R., & Barros, H. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107081525 · Cited by 35
Transcriptional Regulation of the Mouse Gene Encoding the α-4 Subunit of the GABAA Receptor
Ma, L., Li-hua, S., Radoi, G. E., & Harrison, N. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406827200 · Cited by 40
Saavedra, M., Contreras, C. M., Azamar-Arizmendi, G., & Hernández-Lozano, M. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.12.016 · Cited by 37
“, 2000), however, flumazenil during progesterone withdrawal exerts an anxiolytic action (Smith et al., 1998).”
BackgroundLöfgren, M., Johansson, I., Meyerson, B. J., Lundgren, P., & Bäckström, T. C. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.03.002 · Cited by 41
Kita, A., Kinoshita, T., Kohayakawa, H., Furukawa, K., & Akaike, A. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.018 · Cited by 44
“…progesterone and manipulations that alter endogenous allopregnanolone levels have been reported to induce withdrawal symptoms, such as anxiety or convulsion after abrupt cessation of repeated administration in rats and mice (Moran and Smith, 1998; Smith et al., 1998; Gulinello et al., 2002).”
BackgroundNett, S. T., Jorge-Rivera, J. C., Myers, M., Clark, A. S., & Henderson, L. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.1.192 · Cited by 35
“Moreover, our results show that there are no significant differences in the expres- the insensitivity to BZ anxiolytic drugs that is associated with PMS and postpartum syndrome (Smith et al. 1998).sion of any of the three a transcripts between male and female rats.”
3α-Hydroxy-5α-pregnan-20-one exposure reduces GABAA receptor α4 subunit mRNA levels
Grobin, A. C., & Morrow, A. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00797-4 · Cited by 34
Effects of progesterone or neuroactive steroid?
Morrow, A. L., VanDoren, M. J., & Devaud, L. L. (1998) · Nature · doi:10.1038/27106 · Cited by 34
Neuroactive steroids in neuropsychopharmacology
Rupprecht, R., & Holsboer, F. (2001) · International review of neurobiology · doi:10.1016/s0074-7742(01)46072-7 · Cited by 32
Arnot, M. I., Davies, M., Martin, I. L., & Bateson, A. N. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1115 · Cited by 33
Burt, D. R. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00505-8 · Cited by 39
Progesterone for premenstrual syndrome
Ford, O., Lethaby, A. E., & Roberts, H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003415.pub2 · Cited by 33
Plasticity and function of extrasynaptic GABAA receptors during pregnancy and after delivery
Mostallino, M. C., Sanna, E., Concas, A., Biggio, G., & Follesa, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.013 · Cited by 32
“…the post-partum is characterized by a receptor switch with an increased expression of surface a4bg2 receptors that may determine a reduced inhibition (presumably due to their faster kinetics) and enhanced neuronal excitability and anxiety levels (Smith et al., 1998a, 1998b; Smith et al., 2006).”
Pazol, K., Northcutt, K. V., Patisaul, H. B., Wallen, K., & Wilson, M. E. (2009) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.01.021 · Cited by 35
“Prior research has shown that changes in long-term AP exposure increase α4 subunit expression and that this change is accompanied by a rise in anxiety [29–32].”
BackgroundMethodInfluentialAbrupt rather than gradual hormonal changes induce postpartum blues-like behavior in rats
Doornbos, B., Fokkema, D. S., Molhoek, M., Tanke, M. A. C., Postema, F., & Korf, J. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.10.014 · Cited by 36
Ferrara, G., Serra, M., Zammaretti, F., Pisu, M. G., Panzica, G., Biggio, G., & Eva, C. E. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00559.x · Cited by 34
Impact of Sex: Determination of Alcohol Neuroadaptation and Reinforcement
Wiren, K. M., Hashimoto, J. G., Alele, P. E., Devaud, L. L., Price, K. L., Middaugh, L. D., Grant, K. A., & Finn, D. A. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00032.x · Cited by 32
Premenstrual syndrome, neuroactive steroids and the brain
Sundström, I., Bäckström, T. C., Wang, M., Olsson, T., Seippel, L., & Bixo, M. (1999) · Gynecological Endocrinology · doi:10.3109/09513599909167557 · Cited by 32
Fry, J. P., Li, K. Y., Devall, A., Cockcroft, S., Honour, J. W., & Lovick, T. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12891 · Cited by 35
“…as occurs during the ovarian cycle or by termination of pseudopregnancy or experimentally, after treatment with exogenous steroid, leads to changes in GABAA receptor subunit expression which predispose to anxiety, seizures and hyperalgesia (Smith et al., 1998a,b; Griffiths and Lovick, 2005).”
BackgroundAllosteric modulation of neuronal nicotinic acetylcholine receptors
Buisson, B., & Bertrand, D. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80144-7 · Cited by 40
Matthews, D. B., Kralic, J. E., Devaud, L. L., Fritschy, J., & Morrow, A. L. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741522.x · Cited by 34
“Furthermore, withdrawal from progesterone, a hormone whose metabolites act directly at GABAA receptors, increases hippocampal GABAA receptora4 subunit peptide and decreases the decay constant for GABA currents recorded from hippocampal CA1 pyramidal neurons (Smith et al., 1998).”
BackgroundRegulation of the surface expression of α4β2δ GABAA receptors by high efficacy states
Kuver, A., Shen, H., & Smith, S. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.047 · Cited by 30
Self-citationCalza, A., Sogliano, C., Santoru, F., Marra, C., Angioni, M. M., Mostallino, M. C., Biggio, G., & Concas, A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06696.x · Cited by 36
Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids
Pibiri, F., Nelson, M., Carboni, G., & Pinna, G. (2006) · Neuroreport · doi:10.1097/01.wnr.0000234752.03808.b2 · Cited by 30
Dunn, S. M. J., Davies, M., Muntoni, A. L., & Lambert, J. J. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12539-4 · Cited by 63
Clark, A. S., Myers, M., Robinson, S., Chang, P., & Henderson, L. (1998) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1998.0512 · Cited by 30
“…(for a review, see Herbison 1997), the number of GABAA receptors (Schumacher et al. 1989), the expression of GABAA receptor subunit genes (Herbison & Fënelon 1995) and GABAA receptor function (Smith et al. 1996), have been shown to be regulated by gonadal steroids and to be sexually dimorphic.”
BackgroundHidalgo, R. B., & Sheehan, D. V. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00019-x · Cited by 32
Allopregnanolone Decreases Evoked Dopamine Release Differently in Rats by Sex and Estrous Stage
Dornellas, A. P. S., Macedo, G. C., McFarland, M. H., Gómez‐A, A., O’Buckley, T. K., Cunha, C. D., Morrow, A. L., & Robinson, D. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.608887 · Cited by 32
Gerbatin, R., Augusto, J., Boutouil, H., Reschke, C., & Henshall, D. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114090 · Cited by 23
Gonadal steroids, brain, and behavior: role of context
Rubinow, D. R., & Schmidt, P. J. (2002) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2002.4.2/drubinow · Cited by 30
Menstrual effects on mood symptoms in treated women with bipolar disorder
Sit, D. K. Y., Seltman, H. J., & Wisner, K. L. (2011) · Bipolar Disorders · doi:10.1111/j.1399-5618.2011.00921.x · Cited by 34
Pharmacotherapy of catamenial epilepsy
Reddy, D. (2005) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.16851 · Cited by 29
“This suggests that an abrupt “withdrawal” of allopregnanolone at the onset of menstruation could decrease the inhibitory effect and possibly exacerbate seizures.([16,17])”
BackgroundBitran, D., & Smith, S. S. (2004) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2004.11.001 · Cited by 30
Self-citationHerzog, A., Friedman, M. N., Freund, S., & Pascual-Leone, Á. (2001) · Epilepsy & Behavior · doi:10.1006/ebeh.2001.0232 · Cited by 26
Sabaliauskas, N. A., Shen, H., Homanics, G. E., Smith, S. S., & Aoki, C. J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.035 · Cited by 31
Self-citationDaendee, S., Thongsong, B., & Kalandakanond‐Thongsong, S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.03.008 · Cited by 31
Progesterone: Synthesis, Metabolism, Mechanism of Action, and Effects in the Nervous System
Schumacher, M., Zhu, X., & Guennoun, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00054-7 · Cited by 31
Galli, R., Luisi, M., Pizzanelli, C., Monteleone, P., Casarosa, E., Iudice, A., & Murri, L. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.07600.x · Cited by 31
Hippocampal Neurons Express GABAAReceptor Insensitive to Diazepam in Hyperexcitable Conditions
Kapur, J. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01563.x · Cited by 28
Towards a translational model of panic attack.
Schenberg, L. C. (2010) · Psychology & Neuroscience · doi:10.3922/j.psns.2010.1.003 · Cited by 35
“Thus, allopregnanolone rather than progesterone is the active compound (Smith et al., 1998).”
BackgroundYe, Z., McGee, T. P., Houston, C. M., & Brickley, S. G. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00203 · Cited by 28
Allopregnanolone enhancement of GABAergic transmission in rat medial preoptic area neurons
Uchida, S., Noda, E., Kakazu, Y., Mizoguchi, Y., Akaike, N., & Nabekura, J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00049.2002 · Cited by 27
Mostallino, M. C., Mascia, M. P., Pisu, M. G., Busonero, F., Talani, G., & Biggio, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.021 · Cited by 27
Mostallino, M. C., Mura, M. L., Maciocco, E., Murru, L., Sanna, E., & Biggio, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04055.x · Cited by 28
“…are consistent with previous in vivo studies showing that combined short-term administration of oestradiol and progesterone as well as progesterone withdrawal increased the abundance of d and a4 subunits in the rat hippocampus (Smith et al. 1998a,b; Sundstrom-Poromaa et al. 2002; Shen et al. 2005).”
BackgroundResultInfluentialSharma, A. N., Chopde, C. T., Hirani, K., Kokare, D. M., & Ugale, R. R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.025 · Cited by 28
Follesa, P., Biggio, F., Mancuso, L., Cabras, S., Caria, S., Gorini, G., Manca, A., Orrù, A., & Biggio, G. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.10.011 · Cited by 26
Schloemer, N., Lenz, M., Tegenthoff, M., Dinse, H. R., & Höffken, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-79389-6 · Cited by 25
5α‐Reduced glucocorticoids exhibit dissociated anti‐inflammatory and metabolic effects
Yang, C., Nixon, M., Kenyon, C. J., Livingstone, D., Duffin, R., Rossi, A., Walker, B., & Andrew, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01465.x · Cited by 34
“Some 5a-reduced metabolites of steroid hormones have biological activity, including testosterone (Siiteri and Wilson, 1974), aldosterone (Kenyon et al., 1983; 1985; Gorsline et al., 1986) and progesterone (Smith et al., 1998).”
BackgroundBäckström, T. C., Bixo, M., Nyberg, S., & Savic, I. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.014 · Cited by 28
“…for this finding could be found in animal studies showing that flumazenil changes its effect from being a benzodiazepine antagonist or inert compound alone to becoming an agonist due to an up-regulation of the a4 subunit of the GABA-A receptor (Smith et al., 1998; Gangisetty and Reddy, 2010).”
BackgroundInfluentialEstrada-Camarena, E. M., Sollozo-Dupont, I., Islas-Preciado, D., González-Trujano, M. E., Carro-Juárez, M., & López‐Rubalcava, C. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112006 · Cited by 24
Tonkiss, J., Trzcińska, M., Shultz, P. L., Vincitore, M., & Galler, J. R. (2000) · Behavioural Pharmacology · doi:10.1097/00008877-200009000-00001 · Cited by 24
Neurosteroids and the Nervous System
King, S. R. (2012) · SpringerBriefs in neuroscience · doi:10.1007/978-1-4614-5559-2 · Cited by 22
GABAA receptor plasticity in alcohol withdrawal
Olsen, R. W., & Spigelman, I. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02836.x · Cited by 24
Neonatal allopregnanolone levels alteration: Effects on behavior and role of the hippocampus
Darbra, S., Mòdol, L., Llidó, A., Casas, C., Vallée, M., & Pallarés, M. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.07.007 · Cited by 29
“…only shortterm steroid treatment (3a-5b-tetrahydroprogesterone or 17bestradiol + progesterone) (Shen et al., 2005), but also AlloP (Smith et al., 2006) or progesterone withdrawal (Gulinello et al., 2002; Smith et al., 1998), increase d GABAAR subunit expression in CA1 hippocampus of female rats.”
BackgroundHyperexcitability induced by GABA withdrawal facilitates hippocampal long-term potentiation
Casasola, C. D., Montiel, T., Calixto, E., & Brailowsky, S. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.029 · Cited by 24
Biggio, F., Gorini, G., Caria, S., Murru, L., Mostallino, M. C., Sanna, E., & Follesa, P. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.002 · Cited by 29
Mascia, M. P., Biggio, F., Mancuso, L., Cabras, S., Cocco, P. L., Gorini, G., Manca, A., Marra, C., Purdy, R. H., Follesa, P., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040063 · Cited by 23
“An increase in the expression of the 4 subunit after discontinuation of long-term treatment with positive modulators of the GABAA receptor has been associated with the development of withdrawal effects such as anxiety, seizure susceptibility, and behavioral hyperexcitability (Smith et al., 1998).”
InfluentialSex‐steroid actions on neurotransmission
Bicknell, R. J. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199812000-00010 · Cited by 23
Bianchi, M. T., Clark, A. G., & Fisher, J. L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.020 · Cited by 24
“…in thalamus, hippocampus, and cortex (Cope et al., 2005; Liang et al., 2008; Pirker et al., 2000). α4 has been implicated as well in animal models of epilepsy(Brooks-Kayal et al., 1998), and its expression has been linked to neurosteroid hormone status(Hsu et al., 2003; Smith et al., 1998).”
BackgroundGrobin, A. C., Inglefield, J. R., Schwartz‐Bloom, R. D., Devaud, L. L., & Morrow, A. L. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01223-8 · Cited by 22
Britton, K. T., & Koob, G. F. (1998) · Nature · doi:10.1038/31816 · Cited by 25
Reilly, M. T., Crabbe, J. C., Rustay, N. R., & Finn, D. A. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00416-0 · Cited by 23
Specificity protein 4 (Sp4) transcriptionally regulates inhibitory GABAergic receptors in neurons
Nair, B. J., Johar, K., Priya, A., & Wong‐Riley, M. T. T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.005 · Cited by 23
Oral, E., Kirkan, T. S., Yıldırım, A., Kotan, Z. K., Cansever, Z., Özcan, H., Aliyev, E., & Güleç, M. (2015) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2015.03.001 · Cited by 23
Smith, S. S. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000938 · Cited by 21
Self-citationBengtsson, S. K. S., Bäckström, T. C., Brinton, R. D., Irwin, R. W., Johansson, M., Sjöstedt, J., & Wang, M. D. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100206 · Cited by 23
“The α4βδ receptor type is known to be hyper sensitive to APα, showing a positive allosteric effect of flumazenil and to be insensitive to diazepam (Belelli et al., 2002; Gangisetty and Reddy, 2010; Smith et al., 1998).”
BackgroundWei, S., Geng, X., Li, Z., Xu, K., Hu, M., Wu, H., Shi, W., & Qiao, M. (2020) · Aging · doi:10.18632/aging.202249 · Cited by 24
Mòdol, L., Casas, C., Navarro, X., Llidó, A., Vallée, M., Pallarés, M., & Darbra, S. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000989 · Cited by 21
“…as a consequence of allopregnanolone or its precursor progesterone is dependent upon the increased expression of α4βδ GABA receptors in hippocampal area CA1, as shown by the inability of allopregnanolone to induce an anxiogenic profile in δ knock-out mice (Smith et al, 1998; Shen et al., 2007).”
BackgroundRobichaud, M., & Debonnel, G. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570500595x · Cited by 23
Schumacher, M., & Robert, F. (2002) · Elsevier eBooks · doi:10.1016/b978-012532104-4/50057-3 · Cited by 21
Reddy, D., Venkatarangan, L., Chien, B., & Ramu, K. (2005) · Steroids · doi:10.1016/j.steroids.2005.05.007 · Cited by 14
Urschel, H. C., Hanselka, L. L., Gromov, I., White, L., & Baron, M. I. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.10.1170 · Cited by 22
Advances in neurosteroids: role in clinical practice
Pluchino, N., Santoro, A. N., Casarosa, E., Wenger, J. M., Genazzani, A. D., Petignat, P., & Genazzani, A. R. (2013) · Climacteric · doi:10.3109/13697137.2013.809647 · Cited by 22
Stankiewicz, A. M., Gościk, J., Dyr, W., Juszczak, G. R., Ryglewicz, D., Swiergiel, A. H., Wieczorek, M., & Stefański, R. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.10.003 · Cited by 22
“Gabra4 subunit, although expressed in low levels, is crucial for GABA-A receptor activity (Smith et al., 1998).”
Hall, K. A. A., DeLane, S. E., Anderson, G. M., Lago, T. R., Shor, R., Wang, W., Rasmusson, A. M., & Pineles, S. L. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05785-z · Cited by 20
Giuliani, F. A., Escudero, C. G., Casas, S., Bazzocchini, V. S., Yunes, R., Laconi, M. R., & Cabrera, R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.053 · Cited by 20
Progesterone, GABA and mood disorders in women
Rapkin, A. J. (1999) · Archives of Women s Mental Health · doi:10.1007/s007370050041 · Cited by 22
Ma, H., & Penning, T. M. (1999) · Biochemical Journal · doi:10.1042/bj3410853 · Cited by 19
Inhibitory and excitatory synaptic neuroadaptations in the diazepam tolerant brain
Lorenz‐Guertin, J. M., Povysheva, N. V., Chapman, C. A., MacDonald, M. L., Fazzari, M., Nigam, A., Nuwer, J. L., Das, S., Brady, M. L., Vajn, K., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106248 · Cited by 22
Biggio, F., Gorini, G., Caria, S., Murru, L., Sanna, E., & Follesa, P. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04512.x · Cited by 18
Chapter 6 GABAA Receptor Function and Gene Expression During Pregnancy and Postpartum
Biggio, G., Mostallino, M. C., Follesa, P., Concas, A., & Sanna, E. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85006-x · Cited by 21
Foley, C. M., Stanton, J. J., Price, E. M., Cunningham, J. T., Hasser, E. M., & Heesch, C. M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02635-0 · Cited by 20
Binge Drinking: In Search of its Molecular Target via the GABAA Receptor
Yang, A. R. S. T., Liu, J., Yi, H. S., Warnock, K. T., Wang, M., June, H. L., Puché, A. C., Elnabawi, A., Sieghart, W., Aurelian, L., et al. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00123 · Cited by 19
“…Duplicates of punch biopsies obtained from distinct neuroanatomical sites (VP, CeA, BLA, and BST) of HAD and LAD rats were immunoblotted with α1- or α2-specific antibodies, with results quantitated by densitometric scanning as previously described (Smith et al., 1998; Liu et al., 2011).”
MethodKuver, A., & Smith, S. S. (2015) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.11.015 · Cited by 17
“Drugs were applied using a solenoid-controlled micropipette array 50 μm from the cell (Smith et al., 1998) which allowed for rapid onset of drug application (20 ms).”
MethodSelf-citationIba, H., Watanabe, T., Motomura, S., Harada, K., Uesugi, H., Shibahara, T., Kubota, K., Katsurabayashi, S., & Iwasaki, K. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.11.003 · Cited by 18
Talani, G., Licheri, V., Masala, N., Follesa, P., Mostallino, M. C., Biggio, G., & Sanna, E. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1216-8 · Cited by 17
Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder
Oral, E., Özcan, H., Kirkan, T. S., Aşkın, S., Gulec, M., & Aydın, N. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0398-z · Cited by 18
Wihlbäck, A., Poromaa, I. S., Nyberg, S., & Bäckström, T. (2001) · Neuroendocrinology · doi:10.1159/000054658 · Cited by 17
“Clearly, the menstrual cycle offers more complex hormonal changes with rapidly decreasing progesterone levels in the mid to late luteal phase. Given the findings of a decreased benzodiazepine sensitivity during progesterone withdrawal [”
Comparison of the neurophysiological effects of allopregnanolone and ethanol in rats
Slawecki, C. J., Walpole, T., Purdy, R. H., & Ehlers, C. L. (2000) · Psychopharmacology · doi:10.1007/s002139900365 · Cited by 17
Does Stress Trigger Seizures? Evidence from Experimental Models
Reddy, D. S., Thompson, W. J., & Calderara, G. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_191 · Cited by 18
Alshakhouri, M., Sharpe, C. M., Bergin, P., & Sumner, R. L. (2023) · Epilepsia · doi:10.1111/epi.17842 · Cited by 21
“102 Interestingly, it was also found that ALLO withdrawal is followed by a rapid upregulation of δ - containing GABA A receptors and enhanced ALLO sensitivity in the dentate gyrus granule cells but not in CA1 or CA3 pyramidal cells in a mouse model of premenstrual like conditions.”
BackgroundEva, C. E., Mele, P., Collura, D., Nai, A., Pisu, M. G., Serra, M., & Biggio, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05077.x · Cited by 17
Limbic Networks and Epileptiform Synchronization
Behr, C., D’Antuono, M., Hamidi, S., Herrington, R., Lévesque, M., Salami, P., Shiri, Z., Köhling, R., & Avoli, M. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-418693-4.00004-2 · Cited by 20
“In the epileptic rat, a downregulation of the δ subunit as well as an upregulation of the α4 subunit have been reported; these changes have been proposed to contribute to increased excitability (Peng, Huang, Stell, Mody, & Houser, 2004; Smith et al., 1998).”
BackgroundA Neural Systems Approach to the Study of the Respiratory-Type Panic Disorder
Schenberg, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-12538-1_2 · Cited by 15
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.